Under construction – not a live service
Sign in
Taking people in FranceNo phase

Following adults with lupus over time in a multidisciplinary clinic

Follows adults with systemic lupus erythematosus through a multidisciplinary clinic in Brest, France.

Plain-language title generated from the registry record
Registry title: Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU

Key facts

Where
Brest, FranceSee the site

Where in France

  • CHRU de BrestBrest, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital, Brest
Trial code
NCT06551389
Record updated
25 June 2026
Original description
Systemic lupus erythematosus is a complex systemicautoimmune disease that can affect most organs of the human body.Read full original descriptionShow less

Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU

Systemic lupus erythematosus is a complex systemicautoimmune disease that can affect most organs of the human body.

Although they are many recommendations on the diagnosis and managment of SLE, diagnosis and therapeutic managment is still challenging.

A pluridisciplinary consultation grouping rheumatologist, nephrologist, dermatologist, gynecologist, internist and immunologists has been set up in 2009 at the university hospital of Brest.

The investigators would like to identify in a longitudinal cohort the occurrence of the different clinico-biological and immunological patterns of systemic lupus erythematosus patients during our multidisciplinary consultation.

It is now crucial to organize a standardized data collection of these patients in order to evaluate our pratices, to be able to study the epidemiology of SLE in our city, and to promote this initiative at national and international level.

Inclusion: Any patient over 18 years old of the multidisciplinary consultation.

Exclusion: Opposition of patient.

ClinicalTrials.gov NCT06551389